<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: 7 sur 7 &#8211; ‘Covid – formes légère et modérée : L’étude ANTICOV montre que l’association nitazoxanide + ciclésonide ne réduit pas le risque d’hospitalisation’	</title>
	<atom:link href="https://anticov.org/in-the-media/2022/7-sur-7-covid-formes-legere-et-moderee-letude-anticov-montre-que-lassociation-nitazoxanide-ciclesonide-ne-reduit-pas-le-risque-dhospitalisation/feed/" rel="self" type="application/rss+xml" />
	<link>https://anticov.org/in-the-media/2022/7-sur-7-covid-formes-legere-et-moderee-letude-anticov-montre-que-lassociation-nitazoxanide-ciclesonide-ne-reduit-pas-le-risque-dhospitalisation/</link>
	<description>Platform trial to find early treatment options for COVID-19 in low-resource settings</description>
	<lastBuildDate>Thu, 03 Mar 2022 09:08:27 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.7.1</generator>
</channel>
</rss>
